Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.

Standard

Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. / Aydin, Muhammet Ali; Hartel, Friederike; Schlüter, Michael; Butter, Christian; Köbe, Julia; Seifert, Martin; Gosau, Nils; Hoffmann, Boris; Hoffmann, Mathias; Vettorazzi, Eik; Wilke, Iris; Wegscheider, Karl; Reichenspurner, Hermann; Eckardt, Lars; Steven, Daniel; Willems, Stephan.

in: CIRC-ARRHYTHMIA ELEC, Jahrgang 5, Nr. 5, 5, 2012, S. 913-919.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Aydin, MA, Hartel, F, Schlüter, M, Butter, C, Köbe, J, Seifert, M, Gosau, N, Hoffmann, B, Hoffmann, M, Vettorazzi, E, Wilke, I, Wegscheider, K, Reichenspurner, H, Eckardt, L, Steven, D & Willems, S 2012, 'Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.', CIRC-ARRHYTHMIA ELEC, Jg. 5, Nr. 5, 5, S. 913-919. <http://www.ncbi.nlm.nih.gov/pubmed/22923274?dopt=Citation>

APA

Aydin, M. A., Hartel, F., Schlüter, M., Butter, C., Köbe, J., Seifert, M., Gosau, N., Hoffmann, B., Hoffmann, M., Vettorazzi, E., Wilke, I., Wegscheider, K., Reichenspurner, H., Eckardt, L., Steven, D., & Willems, S. (2012). Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. CIRC-ARRHYTHMIA ELEC, 5(5), 913-919. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22923274?dopt=Citation

Vancouver

Bibtex

@article{19eb580038184b8f862f595cc4a971af,
title = "Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.",
abstract = "Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD in a clinical setting.",
keywords = "Adult, Germany, Humans, Male, Aged, Female, Middle Aged, Treatment Outcome, Follow-Up Studies, Logistic Models, Magnetic Resonance Imaging, Patient Selection, Echocardiography, Stroke Volume, Primary Prevention, Death, Sudden, Cardiac/*prevention & control, *Defibrillators, Implantable, Secondary Prevention, Tachycardia, Ventricular/physiopathology/*therapy, Adult, Germany, Humans, Male, Aged, Female, Middle Aged, Treatment Outcome, Follow-Up Studies, Logistic Models, Magnetic Resonance Imaging, Patient Selection, Echocardiography, Stroke Volume, Primary Prevention, Death, Sudden, Cardiac/*prevention & control, *Defibrillators, Implantable, Secondary Prevention, Tachycardia, Ventricular/physiopathology/*therapy",
author = "Aydin, {Muhammet Ali} and Friederike Hartel and Michael Schl{\"u}ter and Christian Butter and Julia K{\"o}be and Martin Seifert and Nils Gosau and Boris Hoffmann and Mathias Hoffmann and Eik Vettorazzi and Iris Wilke and Karl Wegscheider and Hermann Reichenspurner and Lars Eckardt and Daniel Steven and Stephan Willems",
year = "2012",
language = "English",
volume = "5",
pages = "913--919",
journal = "CIRC-ARRHYTHMIA ELEC",
issn = "1941-3149",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.

AU - Aydin, Muhammet Ali

AU - Hartel, Friederike

AU - Schlüter, Michael

AU - Butter, Christian

AU - Köbe, Julia

AU - Seifert, Martin

AU - Gosau, Nils

AU - Hoffmann, Boris

AU - Hoffmann, Mathias

AU - Vettorazzi, Eik

AU - Wilke, Iris

AU - Wegscheider, Karl

AU - Reichenspurner, Hermann

AU - Eckardt, Lars

AU - Steven, Daniel

AU - Willems, Stephan

PY - 2012

Y1 - 2012

N2 - Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD in a clinical setting.

AB - Recently, subcutaneous implantable cardioverter-defibrillator (S-ICD) has become available. The aim of our study was to assess the efficacy of S-ICD in a clinical setting.

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Treatment Outcome

KW - Follow-Up Studies

KW - Logistic Models

KW - Magnetic Resonance Imaging

KW - Patient Selection

KW - Echocardiography

KW - Stroke Volume

KW - Primary Prevention

KW - Death, Sudden, Cardiac/prevention & control

KW - Defibrillators, Implantable

KW - Secondary Prevention

KW - Tachycardia, Ventricular/physiopathology/therapy

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Treatment Outcome

KW - Follow-Up Studies

KW - Logistic Models

KW - Magnetic Resonance Imaging

KW - Patient Selection

KW - Echocardiography

KW - Stroke Volume

KW - Primary Prevention

KW - Death, Sudden, Cardiac/prevention & control

KW - Defibrillators, Implantable

KW - Secondary Prevention

KW - Tachycardia, Ventricular/physiopathology/therapy

M3 - SCORING: Journal article

VL - 5

SP - 913

EP - 919

JO - CIRC-ARRHYTHMIA ELEC

JF - CIRC-ARRHYTHMIA ELEC

SN - 1941-3149

IS - 5

M1 - 5

ER -